Based on our recent findings, five biomarkers (VSIG4, OPN, VCAM1, ALCAM, and TNFRSF1B) were selected for the development of the smartphone-based multiplexed biomarker detection platform for LN [15]. The gene discussed is VSIG4; the disease is lobular neoplasia.